Target intelligence / Profile preview

PHD finger protein 20 (PHF20)

Target
PHF20
Molecular classification
Epigenetic regulator, Chromatin-associated protein, Transcription factor, Histone modification, Methyllysine effector, Reader of methylated lysine
01

Overview

PHD finger protein 20 (PHF20) is a multidomain, chromatin-associated protein that acts as a methyllysine effector, binding specifically to methylated lysine residues on histones and non-histone proteins. PHF20 contains multiple domains, including Tudor, PHD finger, MBT, and AT-hook, enabling it to recognize diverse epigenetic marks. It is a component of the MOF-NSL histone acetyltransferase complex, involved in the acetylation of histone H4 and regulation of gene expression via chromatin remodeling. PHF20 is critical for the stabilization and activation of the tumor suppressor protein p53 in response to DNA damage, enhancing p53’s effects on cell cycle arrest, apoptosis, and DNA repair. It also directly interacts with and regulates the transcription factor Runx2 to promote osteoblast differentiation, with knockout models indicating essential roles in normal skeletal development. In addition, PHF20 acts as an epigenetic reader, influencing genes related to autophagy and other pathways. PHF20 is associated with certain cancer antigens and may be dysregulated in malignancies, implicating a potential role as a tumor biomarker. No drugs targeting PHF20 are currently reported, but its central epigenetic regulatory roles make it a protein of therapeutic interest in cancer and developmental disorders.

Other names
C20orf104GLEA2HCA58NZFTZPdJ1121G12.1TDRD20AGlioma-expressed antigen 2Hepatocellular carcinoma-associated antigen 58Novel zinc finger proteinTranscription factor TZPtudor domain containing 20A
02

Biological functions

Regulation of gene transcriptionEpigenetic modificationDNA bindingProtein-protein interaction (notably with p53 and Runx2)Regulation of osteoblast differentiationStabilization and activation of p53Autophagy gene regulation
03

Disease associations

CancerOsteogenesis/bone development disordersPotential roles in neurodegenerative diseases (based on autophagy control)
04

Safety considerations

Potential impact on epigenetic regulation and tumor suppression (risk if targeted improperly)Potential developmental impacts due to role in skeletal formation
05

Biomarkers

Glioma-expressed antigen 2Hepatocellular carcinoma-associated antigen 58

Beyond the preview

Go deeper on PHD finger protein 20 (PHF20).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PHD finger protein 20 (PHF20).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call